Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunity

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

limma powers differential expression analyses for RNA-sequencing and microarray studies

Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Safety, activity, and immune correlates of anti–PD-1 antibody in cancer

Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628 · see citing works

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829 · see citing works

PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works

voom: precision weights unlock linear model analysis tools for RNA-seq read counts

Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155 · see citing works

Molecular and cellular insights into T cell exhaustion

Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652 · see citing works

Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121 · see citing works

Smart-seq2 for sensitive full-length transcriptome profiling in single cells

Picelli, S., Björklund, Å. K., Faridani, O. R., Sagasser, S., Winberg, G., & Sandberg, R. (2013) · Nature Methods · doi:10.1038/nmeth.2639 · Cited by 2,358 · see citing works

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Miller, B. C., Sen, D. R., Al Abosy, R., Bi, K., Virkud, Y. V., LaFleur, M. W., Yates, K. B., Lako, A., Felt, K., Naik, G. S., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0312-6 · Cited by 2,087 · see citing works

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · see citing works

Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy

Siddiqui, I., Schaeuble, K., Chennupati, V., Fuertes Marraco, S. A., Calderon-Copete, S., Pais Ferreira, D., Carmona, S. J., Scarpellino, L., Gfeller, D., Pradervand, S., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.021 · Cited by 1,679 · see citing works

Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

Pauken, K. E., Sammons, M. A., Odorizzi, P. M., Manne, S., Godec, J., Khan, O., Drake, A. M., Chen, Z., Sen, D. R., Kurachi, M., et al. (2016) · Science · doi:10.1126/science.aaf2807 · Cited by 1,348 · see citing works

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,277 · see citing works

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy

Khalil, D. N., Smith, E. L., Brentjens, R. J., & Wolchok, J. D. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.25 · Cited by 1,151 · see citing works

Molecular and functional profiling of memory CD8 T cell differentiation.

Kaech, S., Hemby, S., Kersh, E., & Ahmed, R. (2002) · Cell · doi:10.1016/s0092-8674(02)01139-x · Cited by 1,081 · see citing works

T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.

Utzschneider, D. T., Charmoy, M., Chennupati, V., Pousse, L., Ferreira, D., Calderon-Copete, S. P., Danilo, M., Alfei, F., Hofmann, M., Wieland, D., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.021 · Cited by 1,026 · see citing works

The epigenetic landscape of T cell exhaustion

Sen, D. R., Kaminski, J., Barnitz, R. A., Kurachi, M., Gerdemann, U., Yates, K. B., Tsao, H.-W., Godec, J., LaFleur, M. W., Brown, F. D., et al. (2016) · Science · doi:10.1126/science.aae0491 · Cited by 986 · see citing works

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

Overwijk, W. W., Theoret, M. R., Finkelstein, S. E., Surman, D. R., de Jong, L. A., Vyth‐Dreese, F. A., Dellemijn, T. A. M., Antony, P. A., Spiess, P. J., Palmer, D. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030590 · Cited by 927 · see citing works

JNK is involved in signal integration during costimulation of T lymphocytes

Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M., & Ben‐Neriah, Y. (1994) · Cell · doi:10.1016/0092-8674(94)90056-6 · Cited by 907 · see citing works

c-Jun overexpression in CAR T cells induces exhaustion resistance

Lynn, R. C., Weber, E. W., Sotillo, E., Gennert, D., Xu, P., Good, Z., Anbunathan, H., Lattin, J., Jones, R., Tieu, V., et al. (2019) · Nature · doi:10.1038/s41586-019-1805-z · Cited by 891 · see citing works

The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells

Martinez, G. J., Pereira, R. M., Äijö, T., Kim, E. Y., Marangoni, F., Pipkin, M. E., Togher, S., Heissmeyer, V., Zhang, Y. C., Crotty, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.006 · Cited by 857 · see citing works

A requirement for neuropilin-1 in embryonic vessel formation

Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 828 · see citing works

Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development.

Gu, C.-H., Rodríguez, E., Reimert, D. V., Shu, T., Fritzsch, B., Richards, L. J., Kolodkin, A., & Ginty, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00169-2 · Cited by 756 · see citing works

An intra-tumoral niche maintains and differentiates stem-like CD8 T cells

Jansen, C. S., Prokhnevska, N., Master, V., Sanda, M., Carlisle, J., Bilen, M., Cardenas, M., Wilkinson, S., Lake, R., Sowalsky, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1836-5 · Cited by 724 · see citing works

Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice.

Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., & Fujisawa, H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80392-x · Cited by 709 · see citing works

Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?

Fares, C. M., Allen, E. M. V., Drake, C. G., Allison, J. P., & Hu‐Lieskovan, S. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_240837 · Cited by 648 · see citing works

Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.005 · Cited by 627 · see citing works

The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness

Wu, T., Ji, Y., Moseman, E. A., Xu, H. C., Manglani, M., Kirby, M., Anderson, S. M., Handon, R., Kenyon, E., Elkahloun, A. G., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aai8593 · Cited by 614 · see citing works

Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis

Delgoffe, G. M., Woo, S.-R., Turnis, M. E., Gravano, D. M., Guy, C., Overacre, A. E., Bettini, M. L., Vogel, P., Finkelstein, D., Bonnevier, J., et al. (2013) · Nature · doi:10.1038/nature12428 · Cited by 587 · see citing works

Network Analysis Reveals Centrally Connected Genes and Pathways Involved in CD8+ T Cell Exhaustion versus Memory

Doering, T. A., Crawford, A., Angelosanto, J., Paley, M., Ziegler, C. G. K., & Wherry, E. J. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.021 · Cited by 542 · see citing works

Antigen-independent memory CD8 T cells do not develop during chronic viral infection

Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N., & Ahmed, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407192101 · Cited by 495 · see citing works

Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection

Man, K., Gabriel, S. S., Liao, Y., Gloury, R., Preston, S., Henstridge, D. C., Pellegrini, M., Zehn, D., Berberich‐Siebelt, F., Febbraio, M. A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.021 · Cited by 489 · see citing works

Frontline: Neuropilin‐1: a surface marker of regulatory T cells

Bruder, D., Probst-Kepper, M., Westendorf, A., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J., & Hansen, W. (2004) · European Journal of Immunology · doi:10.1002/eji.200324799 · Cited by 475 · see citing works

CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles

Leong, Y. A., Chen, Y., Hong, S. L., Wu, D., Man, K., Deleage, C., Minnich, M., Meckiff, B. J., Wei, Y.-B., Hou, Z.-H., et al. (2016) · Nature Immunology · doi:10.1038/ni.3543 · Cited by 449 · see citing works

The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets

Yang, C. Y., Best, J. A., Knell, J., Yang, E., Sheridan, A. D., Jesionek, A. K., Li, H. S., Rivera, R. R., Lind, K. C., D’Cruz, L. M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2158 · Cited by 411 · see citing works

Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity

Maekawa, Y., Minato, Y., Ishifune, C., Kurihara, T., Kitamura, A., Kojima, H., Yagita∥, H., Sakata‐Yanagimoto, M., Saito, T., Taniuchi, I., et al. (2008) · Nature Immunology · doi:10.1038/ni.1649 · Cited by 269 · see citing works

Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy

Roy, S., Bag, A. K., Singh, R. K., Talmadge, J. E., Batra, S. K., & Datta, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01228 · Cited by 237 · see citing works

Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade

Jadhav, R., Im, S., Hu, B., Hashimoto, M., Li, P., Lin, J., Leonard, W., Greenleaf, W., Ahmed, R., & Goronzy, J. (2019) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1903520116 · Cited by 203 · see citing works

Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells

Ji, Y., Pós, Z., Rao, M., Klebanoff, C. A., Yu, Z., Sukumar, M., Reger, R. N., Palmer, D. C., Borman, Z. A., Muranski, P. J., et al. (2011) · Nature Immunology · doi:10.1038/ni.2153 · Cited by 201 · see citing works

The function and dysfunction of memory CD 8+ T cells in tumor immunity

Reading, J. L., Gálvez‐Cancino, F., Swanton, C., Lladser, Á., Peggs, K. S., & Quezada, S. A. (2018) · Immunological Reviews · doi:10.1111/imr.12657 · Cited by 182 · see citing works

Smart-seq2 for sensitive full-length transcriptome profiling in single cells

Picelli, S., Björklund, Å. K., Faridani, O. R., Sagasser, S., Winberg, G., & Sandberg, R. (2013) · F1000Research · doi:10.7490/f1000research.1094785.1 · Cited by 173 · see citing works

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1

Leclerc, M., Voilin, E., Gros, G., Corgnac, S., de Montpréville, V., Validire, P., Bismuth, G., & Mami‐Chouaib, F. (2019) · Nature Communications · doi:10.1038/s41467-019-11280-z · Cited by 153 · see citing works

Neuropilin‐1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer

Battaglia, A., Buzzonetti, A., Monego, G., Peri, L., Ferrandina, G., Fanfani, F., Scambia, G., & Fattorossi, A. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02737.x · Cited by 112 · see citing works

CD8 T-Cell Memory Differentiation during Acute and Chronic Viral Infections

Kalia, V., Sarkar, S., & Ahmed, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_7 · Cited by 85 · see citing works

Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer

Battaglia, A., Buzzonetti, A., Baranello, C., Ferrandina, G., Martinelli, E., Fanfani, F., Scambia, G., & Fattorossi, A. (2009) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-008-0646-7 · Cited by 83 · see citing works

Induction of Postsurgical Tumor Immunity and T-Cell Memory by a Poorly Immunogenic Tumor

Zhang, P., Côté, A. L., de Vries, V. C., Usherwood, E. J., & Turk, M. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1264 · Cited by 80 · see citing works

The Transcription Factor TCF1 Preserves the Effector Function of Exhausted CD8 T Cells During Chronic Viral Infection

Wang, Y.-F., Hu, J., Li, Y.-D., Xiao, M., Wang, H.-Q., Tian, Q., Li, Z.-R., Tang, J.-F., Hu, L., Tan, Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00169 · Cited by 79 · see citing works

Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma

Byrne, K. T., Côté, A. L., Zhang, P., Steinberg, S. M., Guo, Y., Allie, R., Zhang, W., Ernstoff, M. S., Usherwood, E. J., & Turk, M. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44849 · Cited by 77 · see citing works

Differential requirements for Tcf1 long isoforms in CD8+ and CD4+ T cell responses to acute viral infection

Gullicksrud, J. A., Li, F.-Y., Xing, S.-J., Zeng, Z., Peng, W.-Q., Badovinac, V., Harty, J., & Xue, H.-H. (2017) · Journal of Immunology · doi:10.4049/jimmunol.1700595 · Cited by 65 · see citing works

mTOR Complex Signaling through the SEMA4A–Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells

Ito, D., Nojima, S., Nishide, M., Okuno, T., Takamatsu, H., Kang, S., Kimura, T., Yoshida, Y., Morimoto, K., Maeda, Y., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403038 · Cited by 53 · see citing works

Local Induction of Immunosuppressive CD8+ T Cells in the Gut-Associated Lymphoid Tissues

Fleissner, D., Hansen, W., Geffers, R., Buer, J., & Westendorf, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015373 · Cited by 30 · see citing works

Immunological consequences of tumor excision: From active immunity to immunological memory

Bursuker, I., & North, R. J. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910370216 · Cited by 22 · see citing works

Neuropilin-1 Expression Is Induced on Tolerant Self-Reactive CD8+ T Cells but Is Dispensable for the Tolerant Phenotype

Jackson, S. R., Berrien-Elliott, M., Yuan, J.-Y., Hsueh, E., & Teague, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110707 · Cited by 20 · see citing works

Self-reactivity as the necessary cost of maintaining a diverse memory T-cell repertoire

Singh, N. J. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw092 · Cited by 11 · see citing works

Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion

Scharping, N. E., Rivadeneira, D. B., Menk, A. V., Vignali, P. D. A., Ford, B. R., Rittenhouse, N. L., Peralta, R., Wang, Y., Wang, Y., DePeaux, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00834-9 · Cited by 897 · see citing works

IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor

Liu, Y., Zhou, N., Zhou, L., Wang, J., Zhou, Y., Zhang, T., Fang, Y., Deng, J., Gao, Y., Liang, X., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00850-9 · Cited by 372 · see citing works

COVID-19 mRNA vaccines: Platforms and current developments

Szabó, G. T., Mahiny, A. J., & Vlatkovic, I. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.02.016 · Cited by 308 · see citing works

Stem-like exhausted and memory CD8+ T cells in cancer

Gebhardt, T., Park, S. L., & Parish, I. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00615-0 · Cited by 216 · see citing works

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

Chuckran, C. A., Liu, C., Bruno, T. C., Workman, C. J., & Vignali, D. A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000967 · Cited by 147 · see citing works

Competition for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue- Resident Memory T Cells in the Epidermal Niche

Hirai, T., Yang, Y., Zenke, Y., Li, H., Chaudhri, V. K., Diaz, J. S. D. L. C., Zhou, P. Y., Nguyen, B. A., Bartholin, L., Workman, C. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.022 · Cited by 120 · see citing works

Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis

Li, H., Wang, M., Huang, B., Zhu, S., Zhou, J., Chen, D., Cui, R., Zhang, M., & Sun, Z. (2021) · Nature Communications · doi:10.1038/s41467-021-27485-0 · Cited by 113 · see citing works

Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients

Feng, Y., Ma, W., Zang, Y., Guo, Y., Li, Y., Zhang, Y., Dong, X., Liu, Y., Zhan, X., Pan, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54710-3 · Cited by 116 · see citing works

Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment

Choi, J., Sun, I., Hwang, H. S., Yoon, H. Y., & Kim, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114344 · Cited by 98 · see citing works

The GPCR–Gαs–PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure

Wu, V. H., Yung, B. S., Faraji, F., Saddawi‐Konefka, R., Wang, Z., Wenzel, A. T., Song, M., Pagadala, M. S., Clubb, L. M., Chiou, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01529-7 · Cited by 98 · see citing works

Resident memory T cells form during persistent antigen exposure leading to allograft rejection

Abou‐Daya, K. I., Tieu, R., Zhao, D., Rammal, R., Sacirbegovic, F., Williams, A. L., Shlomchik, W. D., Oberbarnscheidt, M. H., & Lakkis, F. G. (2021) · Science Immunology · doi:10.1126/sciimmunol.abc8122 · Cited by 92 · see citing works

Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity

Zhang, J., Qiu, J., Zhou, W., Cao, J., Hu, X., Mi, W., Su, B., He, B., Qiu, J., & Shen, L. (2022) · Nature Immunology · doi:10.1038/s41590-021-01097-8 · Cited by 82 · see citing works

TGF-β regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection

Hu, Y., Hudson, W. H., Kissick, H. T., Medina, C. B., Baptista, A. P., Ma, C., Liao, W., Germain, R. N., Turley, S. J., Zhang, N., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20211574 · Cited by 81 · see citing works

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Xie, Y., Xie, F., Zhang, L., Zhou, X., Huang, J., Wang, F., Jin, J., Zhang, L., Zeng, L., & Zhou, F. (2021) · Advanced Science · doi:10.1002/advs.202101672 · Cited by 71 · see citing works

IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model

Lutz, V., Hellmund, V. M., Picard, F. S. R., Raifer, H., Ruckenbrod, T., Klein, M., Bopp, T., Savai, R., Duewell, P., Keber, C. U., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0398 · Cited by 70 · see citing works

IFNγ-induction of TH1-like regulatory T cells controls antiviral responses

Gocher, A. M., Cui, J., Szymczak-Workman, A. L., Vignali, K. M., Latini, J., Pieklo, G. P., Kimball, J. C., Avery, L., Cipolla, E., Huckestein, B. R., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01453-w · Cited by 70 · see citing works

Mechanisms of CD8+ T cell exclusion and dysfunction in cancer resistance to anti-PD-(L)1.

Mortaezaee, K., & Majidpoor, J. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.114824 · Cited by 65 · see citing works

Cellular landscape of tumour microenvironment in prostate cancer

Feng, D., Xiong, Q., Wei, Q., & Yang, L. (2022) · Immunology · doi:10.1111/imm.13456 · Cited by 61 · see citing works

Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance

Wagle, M. V., Vervoort, S. J., Kelly, M. J., Byl, W. V. D., Peters, T. J., Martin, B. P., Martelotto, L. G., Nüssing, S., Ramsbottom, K. M., Torpy, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23044-9 · Cited by 59 · see citing works

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation

Zhang, P., Chen, L., Zhou, F., He, Z., Wang, G., & Luo, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05696-1 · Cited by 59 · see citing works

Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment

Guan, Q., Han, M., Guo, Q., Yan, F., Wang, M., Ning, Q., & Xi, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1204363 · Cited by 54 · see citing works

Targeting neuropilin-1 interactions is a promising anti-tumor strategy

Liu, S., Zhong, L.-P., He, J., & Zhao, Y.-X. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001200 · Cited by 43 · see citing works

Role of Neuropilin 1 in COVID-19 Patients with Acute Ischemic Stroke

Al-Thomali, A. W., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., WAARD, M. M. D., Sabatier, J., Khalil, A. A. K., Saad, ‏. M., & Batiha, G. E. (2022) · Biomedicines · doi:10.3390/biomedicines10082032 · Cited by 49 · see citing works

Engaging stemness improves cancer immunotherapy

Dianat‐Moghadam, H., Sharifi, M., Salehi, R., Keshavarz, M., Shahgolzari, M., & Amoozgar, Z. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216007 · Cited by 45 · see citing works

Diselenide‐Based Dual‐Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy

Wan, S., Ye, M., Yang, Q., Zhang, T., Zhang, M., Ma, X., Xu, J., Wang, S., Wu, Z., Yang, L., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202135 · Cited by 45 · see citing works

A widespread viral entry mechanism: The C-end Rule motif–neuropilin receptor interaction

Balistreri, G., Yamauchi, Y., & Teesalu, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112457118 · Cited by 42 · see citing works

Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer

Chuckran, C. A., Cillo, A., Moskovitz, J., Overacre-Delgoffe, A., Somasundaram, A. S., Shan, F., Magnon, G., Kunning, S., Abécassis, I., Zureikat, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8495 · Cited by 37 · see citing works

Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development

Vlaeminck, Y. D., Bonelli, S., Awad, R. M., Dewilde, M., Rizzolio, S., Lecocq, Q., Bolli, E., Santos, A. R., Laoui, D., Schoonooghe, S., et al. (2020) · Cancers · doi:10.3390/cancers12123582 · Cited by 37 · see citing works

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy

Wan, Z., Sun, R., Liu, Y., Li, S., Sun, J., Li, J., Zhu, J., Moharil, P., Zhang, B., Ren, P., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj4226 · Cited by 35 · see citing works

Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer

Zou, C., Xu, F., Shen, J., & Xu, S. (2022) · Journal of Oncology · doi:10.1155/2022/3997562 · Cited by 35 · see citing works

Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells

Barnkob, M. B., Michaels, Y. S., André, V., Macklin, P. S., Gileadi, U., Valvo, S., Rei, M., Kulicke, C. A., Chen, J., Jain, V., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47424-z · Cited by 34 · see citing works

Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in cervical cancer

Gui, Z., Ye, Y.-Q., Li, Y., Ren, Z., Wei, N., Liu, L., Wang, H., & Zhang, M. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102001 · Cited by 34 · see citing works

Ganoderma lucidum polysaccharides ameliorate lipopolysaccharide-induced acute pneumonia via inhibiting NRP1-mediated inflammation

Zhang, X.-L., Wu, D., Tian, Y., Chen, X.-D., Lan, J., Wei, F.-L., Li, Y., Luo, Y., & Sun, X.-B. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2142615 · Cited by 31 · see citing works

Terminally Exhausted CD8+ T Cells Resistant to PD-1 Blockade Promote Generation and Maintenance of Aggressive Cancer Stem Cells

Chakravarti, M., Dhar, S., Bera, S., Sinha, A., Roy, K., Sarkar, A., Dasgupta, S., Bhuniya, A., Saha, A., Das, J., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-3864 · Cited by 29 · see citing works

Knockdown of integrin β1 inhibits proliferation and promotes apoptosis in bladder cancer cells

Wang, J., Wang, J., Liu, Y., Ji, B., Ding, B., Wang, Y., & Ren, M.-H. (2024) · BioFactors · doi:10.1002/biof.2150 · Cited by 28 · see citing works

Solasonine Induces Apoptosis and Inhibits Proliferation of Bladder Cancer Cells by Suppressing NRP1 Expression

Dong, Y., Hao, L., Shi, Z.-J., Fang, K., Yu, H., Zang, G.-H., Fan, T., & Han, C.-H. (2022) · Journal of Oncology · doi:10.1155/2022/7261486 · Cited by 28 · see citing works

Neuropilin (NRPs) Related Pathological Conditions and Their Modulators

Broz, M., Kolarič, A., Jukič, M., & Bren, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158402 · Cited by 27 · see citing works

Stem-like CD8+ T cells in cancer

Steiner, C., Denlinger, N., Huang, X.-P., & Yang, Y.-P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1426418 · Cited by 26 · see citing works

Potential mechanisms of cancer stem‐like progenitor T‐cell bio‐behaviours

Ni, L. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1817 · Cited by 26 · see citing works

Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment

Li, X., Chen, T., Li, X., Zhang, H., Li, Y., Zhang, S., Luo, S., & Zheng, T. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00564-w · Cited by 27 · see citing works

Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity

Wang, S., Zhao, L., Zhang, X., Zhang, J., Shang, H., & Liang, G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114884119 · Cited by 25 · see citing works

Role of semaphorins, neuropilins and plexins in cancer progression

Fernández‐Nogueira, P., Linzoain-Agos, P., Cueto‐Remacha, M., la Guia-Lopez, I. D., Recalde‐Percaz, L., Parcerisas, A., Gascón, P., Carbó, N., Gutiérrez-Uzquiza, Á., Fuster, G., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217308 · Cited by 24 · see citing works

Neuropilin-1: A Multifaceted Target for Cancer Therapy

Varanasi, S. M., Gulani, Y., Rachamala, H. K., Mukhopadhyay, D., & Angom, R. S. (2025) · Current Oncology · doi:10.3390/curroncol32040203 · Cited by 25 · see citing works

PPARδ inhibition blocks the induction and function of tumor-induced IL-10+ regulatory B cells and enhances cancer immunotherapy

Chen, C., Ma, J., Pi, C., Huang, W., Zhang, T., Fu, C., Liu, W., & Yang, Y. (2023) · Cell Discovery · doi:10.1038/s41421-023-00568-6 · Cited by 22 · see citing works

Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy

Kim, C. H., Lee, E. S., Ko, H., Son, S., Kim, S. H., Lee, C. H., Na, H., Shin, J. M., & Park, J. H. (2024) · Chemistry of Materials · doi:10.1021/acs.chemmater.3c02472 · Cited by 22 · see citing works

Jun, an Oncological Foe or Friend?

Jafri, Z., Li, Y., Zhang, J., O’Meara, C. H., & Khachigian, L. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020555 · Cited by 21 · see citing works

NRP1 instructs IL-17-producing ILC3s to drive colitis progression

Wang, Y., Wang, J., Liu, G., Yi, X., Wu, J., Cao, H., Zhang, L., Zhou, P., Fan, Y., Yu, Y., et al. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01246-7 · Cited by 22 · see citing works

The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer

Sun, H., Li, Y., Zhang, Y., Zhao, X., Dong, X., Guo, Y., Mo, J., Che, N., Ban, X., Li, F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1042835 · Cited by 19 · see citing works

The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies

Heidari‐Foroozan, M., Rezalotfi, A., & Rezaei, N. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2401352 · Cited by 18 · see citing works

Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection

Chapoval, S., & Keegan, A. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00423-y · Cited by 19 · see citing works

Comprehensive analysis of cuproptosis-related immune biomarker signature to enhance prognostic accuracy in gastric cancer

Li, J., Tian, Y., Sun, J., Zeng, Z., Liu, Z., Ma, M., Zheng, Z., He, Y., & Kang, W. (2023) · Aging · doi:10.18632/aging.204646 · Cited by 18 · see citing works

Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance

Wang, Y., Chai, Y., Liu, Y., Liu, X., Zhang, Y., Yang, Z. F., Yin, S., Luo, J., Li, Z., Gu, Y., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.013 · Cited by 17 · see citing works

TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer

Yang, B., Chen, J., & Teng, Y. (2021) · Journal of Immunological Research · doi:10.1155/2021/9994004 · Cited by 15 · see citing works

Predictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy

Ruan, L., Chen, W., Zhao, X., Fang, N., & Li, T. (2022) · Journal of Oncology · doi:10.1155/2022/1084555 · Cited by 16 · see citing works

The interplay between gut bacteria and targeted therapies: implications for future cancer treatments

He, J., Chen, Y., Zhao, H., & Li, Y. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01108-6 · Cited by 19 · see citing works

N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling

Wang, L., Wang, L., Wang, S., Zhou, Z., Liu, Z., Xu, P., Luo, X., Wu, T., Luo, F., & Yan, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.657008 · Cited by 15 · see citing works

Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how

Zhai, Y., Liang, X., & Deng, M. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.04 · Cited by 14 · see citing works

Loss of neuropilin1 inhibits liver cancer stem cells population and blocks metastasis in hepatocellular carcinoma via epithelial-mesenchymal transition

Li, X., Zhou, Y., Hu, J., Bai, Z., Meng, W., Zhang, L., Song, X., Wei, Y., Yan, J., & Zhou, Y. (2020) · Neoplasma · doi:10.4149/neo_2020_200914n982 · Cited by 14 · see citing works

Activin-A impedes the establishment of CD4+ T cell exhaustion and enhances anti-tumor immunity in the lung

Morianos, I., Tsitsopoulou, A., Potaris, Κ., Valakos, D., Fari, O., Vatsellas, G., Bostantzoglou, C., Photiades, A., Gaga, M., Xanthou, G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02092-5 · Cited by 14 · see citing works

Inducing mismatch repair deficiency sensitizes immune-cold neuroblastoma to anti-CTLA4 and generates broad anti-tumor immune memory

El‐Hajjar, M., Gerhardt, L., Hong, M. M. Y., Krishnamoorthy, M., Figueredo, R., Zheng, X., Koropatnick, J. D., & Vareki, S. M. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.08.025 · Cited by 13 · see citing works

13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion

Kirchmair, A., Nemati, N., Lamberti, G., Trefny, M. P., Krogsdam, A., Siller, A., Hörtnagl, P., Schumacher, P., Sopper, S., Sandbichler, A. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267816 · Cited by 13 · see citing works

Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells

Grebinoski, S., Pieklo, G. P., Zhang, Q., Visperas, A., Cui, J., Goulet, J., Xiao, H., Brunazzi, E. A., Cardello, C., Herrada, A. A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300216 · Cited by 13 · see citing works

SEMA3G–NRP1 Signaling Functions as an Immune Checkpoint That Enables Tumor Immune Evasion by Impairing T-cell Cytotoxicity

Chi, H., Deng, S., Xu, K., Zhang, Y., Song, T., Yu, J., Wang, Y., Liu, J., Zhang, Y., Shi, J., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2223 · Cited by 13 · see citing works

Thiol-Responsive Gold Nanodot Swarm with Glycol Chitosan for Photothermal Cancer Therapy

Jo, S., Sun, I., Yun, W. S., Kim, J., Lim, D., Ahn, C.-H., & Kim, K. (2021) · Molecules · doi:10.3390/molecules26195980 · Cited by 13 · see citing works

H19- and hsa-miR-338-3p-mediated NRP1 expression is an independent predictor of poor prognosis in glioblastoma

Liu, Y., Liu, Y., Gao, Y., Wang, L., Shi, H., & Xuan, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260103 · Cited by 13 · see citing works

Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma

Wang, Z., Wang, K., Xue, Y., Chen, M., & Du, Y. (2022) · Journal of Cancer · doi:10.7150/jca.68673 · Cited by 13 · see citing works

pH-Responsive Liposomes Loaded with Targeting Procoagulant Proteins as Potential Embolic Agents for Solid Tumor-Targeted Therapy

Wang, L., Wang, L., Xu, P., Liu, C., Wang, S., Luo, X., Li, M., Liu, J., Zhao, Z., Lai, W., et al. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00912 · Cited by 12 · see citing works

Immunouniverse of SARS-CoV-2

Jiménez, D., & Arias, M. T. (2022) · Immunological Medicine · doi:10.1080/25785826.2022.2066251 · Cited by 12 · see citing works

From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma

Smith, G. T., Radin, D. P., & Tsirka, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958620 · Cited by 12 · see citing works

PHD2 Constrains Antitumor CD8+ T-cell Activity

Donnet, C. B., Acolty, V., Azouz, A., Taquin, A., Henin, C., Cafarello, S. T., Denanglaire, S., Mazzone, M., Oldenhove, G., Léo, O., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0099 · Cited by 12 · see citing works

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1

Rossignol, J., Belaid, Z., Fouquet, G., Guillem, F., Rignault‐Bricard, R., Milpied, P. J., Renand, A., Coman, T., D’Aveni, M., Dussiot, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104353 · Cited by 11 · see citing works

In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution

Fischer, A., Lersch, R., Krätzig, N. D. A., Strong, A. J., Friedrich, M., Weber, J., Engleitner, T., Öllinger, R., Yen, H.-Y., Kohlhofer, U., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100276 · Cited by 10 · see citing works

Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer

Yu, Y., Zeng, H., Jin, K.-F., You, R., Liu, Z.-X., Zhang, H., Liu, C., Su, X., Yan, S., Chang, Y.-Y., et al. (2022) · Cancer Immunology and Immunotherapy · doi:10.1007/s00262-022-03153-0 · Cited by 7 · see citing works

EBV Vaccines in the Prevention and Treatment of Nasopharyngeal Carcinoma

Zhang, W., Wang, C., Meng, Y., He, L., & Dong, M. (2025) · Vaccines · doi:10.3390/vaccines13050478 · Cited by 10 · see citing works

Spatially Resolved Transcriptomics: Revealing Tumor Microenvironment Heterogeneity to Advance Cancer Immunotherapy

Liu, D., Xiao, L. X., Wu, Y., Yue, C., Li, M., Sun, Y., & Yang, C. J. (2025) · Small Methods · doi:10.1002/smtd.202500770 · Cited by 9 · see citing works

The mitochondrial fission protein DRP1 influences memory CD8+ T cell formation and function

Stevens, M. G., Mason, F. M., & Bullock, T. N. J. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad155 · Cited by 9 · see citing works

NRP1 cripples immunological memory

Acharya, N., & Anderson, A. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0759-5 · Cited by 9 · see citing works

Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients

Feng, D., Zhu, W., You, J., Shi, X., Han, P., Wei, W., Wei, Q., & Yang, L. (2022) · Molecules · doi:10.3390/molecules27186000 · Cited by 9 · see citing works

STAT6 Upregulates NRP1 Expression in Endothelial Cells and Promotes Angiogenesis

Gao, P., Ren, G., Liang, J., & Liu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.823377 · Cited by 8 · see citing works

Prediction and therapeutic targeting of the tumor microenvironment-associated gene CTSK in gastric cancer

Bai, Z., Yan, C., & Chang, D. (2023) · Discover Oncology · doi:10.1007/s12672-023-00821-0 · Cited by 8 · see citing works

Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer

Ma, X., Liu, H., Shi, C., Zhao, Y., Wang, H., & Han, Z.-X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27368 · Cited by 7 · see citing works

Distinct roles of ADIPOR1 and ADIPOR2: A pan-cancer analysis

Chen, Z., Yang, H., Ren, Y.-F., Yang, Z., Huang, J.-Z., Li, C., Xiong, Y., & Yu, B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1119534 · Cited by 9 · see citing works

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma

Yang, X., Xu, T., Song, X., & Wu, Y. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s409336 · Cited by 7 · see citing works

Deficiency of inflammation‐sensing protein neuropilin‐2 in myeloid‐derived macrophages exacerbates colitis via NF‐κB activation

Li, T., Ran, J., Miao, Z., Yang, M., Mou, D., Jiang, Y., Xu, X., Xie, Q., & Jin, K. (2023) · The Journal of Pathology · doi:10.1002/path.6221 · Cited by 7 · see citing works

Neuropilin-1 is a valuable biomarker for predicting response of advanced non-small cell lung cancer patients to hypofractionated radiotherapy and PD-1 blockade

Kang, P., Li, Y., Hu, Z., Lei, M., Cheng, J., Guo, X., Zhang, L., Lin, S., & Yuan, Q. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108732 · Cited by 7 · see citing works

A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma

Dai, J., Pan, Y., Chen, Y., & Yao, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1024508 · Cited by 7 · see citing works

Membrane Proteins | The Plexin Family of Transmembrane Receptors

Buck, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00345-5 · Cited by 7 · see citing works

Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer

He, L.-H., Zhang, X.-Z., Lao, M.-Y., Zhang, H.-J., Yang, H.-S., & Bai, X. (2023) · Cancers · doi:10.3390/cancers15082225 · Cited by 6 · see citing works

Neuropilin-1high monocytes protect against neonatal inflammation

Zheng, X.-Q., Lei, W., Zhang, Y.-M., Jin, H., Han, C., Wu, F., Jia, C., Zeng, R.-H., Chen, Z.-H., Zhang, Y.-X., et al. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01157-7 · Cited by 6 · see citing works

Neuropilin-1 Is Expressed on Highly Activated CD4+ Effector T Cells and Dysfunctional CD4+ Conventional T Cells from Naive Mice

Abberger, H., Barthel, R., Bahr, J., Thiel, J., Luppus, S., Buer, J., Westendorf, A. M., & Hansen, W. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100222 · Cited by 6 · see citing works

Comprehensive prognostic and immunological analysis of Ubiquitin Specific Peptidase 28 in pan-cancers and identification of its role in hepatocellular carcinoma cell lines

Zhou, W., Chen, J., & Wang, J. (2023) · Aging · doi:10.18632/aging.204869 · Cited by 6 · see citing works

MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis

Xiang, J.-Y., Ni, Y., Yu, J., Sun, H., Gu, Z., Li, Z., Yang, T., Feng, J., Su, L., Liu, L.-M., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-01059-1 · Cited by 5 · see citing works

High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures

Cabug, A. F., Crawford, J. C., McQuilten, H. A., Foo, I. J. H., Allen, L. F., Gebregzabher, D., Mettelman, R. C., Novak, T., Chou, J. S., Rowntree, L. C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65262-5 · Cited by 5 · see citing works

Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer

Zhang, L., Zhang, B., Li, L., Ye, Y., Wu, Y., Yuan, Q., Xu, W., Wen, X., Guo, X., & Nian, S. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04326-1 · Cited by 5 · see citing works

Using a Supervised Principal Components Analysis for Variable Selection in High‐Dimensional Datasets Reduces False Discovery Rates

Ullah, I., Mengersen, K. L., Pettitt, A. N., & Liquet, B. (2025) · Statistics in Medicine · doi:10.1002/sim.70110 · Cited by 4 · see citing works

Notoginsenoside R1 attenuates idiopathic pulmonary fibrosis through neuropilin-1/type 2 innate lymphoid cells pathway

Yang, M., Fang, Y., Li, X., Yang, B., Ma, Q., Cui, X., Jiang, L., & Ge, F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115385 · Cited by 4 · see citing works

Small molecule inhibitors of the co-receptor neuropilin-1

Liu, Y., Liang, K.-H., Zhang, W., Rao, G.-W., & Zheng, Q. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104523 · Cited by 4 · see citing works

Targeting NRP1 in Endothelial Cells Facilitates the Normalization of Scar Vessels and Prevents Fibrotic Scarring

Wang, Y., Zhou, X., Liu, M., Huang, M., Chen, P., Li, X.-Y., Xue, F., Zhao, W., Liu, D., Li, L., et al. (2025) · Advancement of science · doi:10.1002/advs.202510545 · Cited by 5 · see citing works

A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2

Chen, S., Zhang, L.-M., Song, Y., Xie, K.-Y., Wang, Y., & Liang, Y. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10518-2 · Cited by 3 · see citing works

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy

Chuckran, C. A., Liu, C., Bruno, T. C., Workman, C. J., & Vignali, D. A. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000967 · Cited by 147 · see citing works

NRP1 cripples immunological memory

Acharya, N., & Anderson, A. C. (2020) · Nature Immunology · doi:10.1038/s41590-020-0759-5 · Cited by 9 · see citing works

Neuropilin-1, an immune checkpoint for controlling tumor-specific CD8 T-cell functions whose blockade improves anti-PD-1 immunotherapy

Mami‐Chouaib, F. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.204.supp.241.5

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1

Leclerc, M., Voilin, E., Gros, G., Corgnac, S., de Montpréville, V., Validire, P., Bismuth, G., & Mami‐Chouaib, F. (2019) · Nature Communications · doi:10.1038/s41467-019-11280-z · Cited by 153 · see citing works

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1

Rossignol, J., Belaid, Z., Fouquet, G., Guillem, F., Rignault‐Bricard, R., Milpied, P. J., Renand, A., Coman, T., D’Aveni, M., Dussiot, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104353 · Cited by 11 · see citing works